EMDR vs Ketamine-Assisted Therapy: An Honest Look

EMDR and ketamine-assisted therapy work in entirely different ways. EMDR is a structured psychotherapy using bilateral stimulation to reprocess a distressing memory. Ketamine-assisted therapy uses a dissociative drug under medical supervision to shift brain chemistry for psychological work. Only esketamine (Spravato) is FDA-approved, for treatment-resistant depression; ketamine for PTSD remains off-label and far less established than EMDR.

If you’ve hit a wall with standard treatment, whether that’s PTSD that hasn’t budged or depression that’s outlasted several medications, you’ve probably come across both of these names. They’re not really competing for the same slot the way EMDR and CBT do. One is talk-free psychotherapy; the other is a monitored psychiatric drug treatment with its own approval history, risks, and rules. Here’s what each one actually involves, what the evidence supports, and where the real safety differences sit.

What is ketamine-assisted therapy?

Ketamine was developed in the early 1960s and FDA-approved in 1970 as a fast-acting surgical anesthetic, a use that continues in hospitals and emergency medicine today. Its psychiatric use is much newer. Starting in the early 2000s, small trials found that a low, sub-anesthetic dose given intravenously could ease depression within hours, far faster than a typical antidepressant takes to work. That speed, not its anesthetic history, built the field now marketed as ketamine therapy.

Only one form has cleared the FDA’s bar for a psychiatric use: esketamine, sold as Spravato, a nasal spray built from one half of the ketamine molecule. The FDA approved it in March 2019 for treatment-resistant depression, prescribed alongside an oral antidepressant rather than on its own. Because of dissociation, sedation, and blood-pressure risks flagged in that approval, it can only be given in a certified healthcare setting, with monitoring for at least two hours afterward.

“Ketamine-assisted therapy,” or KAP, usually describes something broader than a Spravato prescription: pairing ketamine, often a lower intramuscular dose or a sublingual lozenge rather than a nasal spray, with structured psychotherapy around it. A prescriber administers or prescribes the drug; a therapist may lead a preparation conversation beforehand and “integration” sessions afterward to work through what came up. Unlike EMDR, there’s no single national training body behind this model, so it’s worth asking any KAP provider directly about their licensing, protocol, and monitoring setup.

A dosing session itself commonly runs 40 minutes to a couple of hours once monitoring is included. Most people describe a dissociative, dreamlike state: a sense of floating or distance from their body, an altered sense of time, sometimes vivid imagery. It isn’t a conversation in the way most therapy is; talking is minimal while the drug is active. Courses are often a series, commonly around six sessions over a few weeks, since a single dose’s effect on mood tends to fade within days.

What is EMDR?

EMDR (Eye Movement Desensitization and Reprocessing) was developed by psychologist Dr. Francine Shapiro in 1987. Its theory, the Adaptive Information Processing model, holds that distress often comes from a memory stored in a raw, unprocessed form. Process the memory, the theory goes, and the distress attached to it eases too.

In a session, you briefly hold a distressing memory in mind while following bilateral stimulation: alternating eye movements, tones, or taps. The process follows a standardized eight-phase protocol, moving from history-taking and preparation through assessment, desensitization, installation, body scan, closure, and reevaluation. You stay verbal and oriented to the room throughout.

Becoming an EMDR clinician requires an EMDRIA-approved basic training: about 50 hours, on top of an existing clinical license. Full EMDRIA certification is a separate, optional step that adds documented client sessions and further consultation.

EMDR vs ketamine-assisted therapy at a glance

	EMDR	Ketamine-Assisted Therapy
Developed	1987, by psychologist Dr. Francine Shapiro	Ketamine approved as an anesthetic in 1970; psychiatric use studied from the early 2000s; esketamine (Spravato) FDA-approved in 2019
What it is	A structured psychotherapy	A prescription drug treatment, sometimes paired with therapy (KAP)
What you do in session	Briefly recall a memory while following bilateral stimulation, staying verbal throughout	Receive ketamine (IV, IM, sublingual, or nasal spray) and enter a monitored, often nonverbal, dissociative state
Session length	60–90 minutes (EMDRIA)	Roughly 40 minutes to a few hours, including required monitoring
Typical course	Often several sessions per target memory	Commonly a series (e.g., six sessions) over a few weeks
FDA-approved for	Not applicable; a psychotherapy, not a drug	Esketamine only, for treatment-resistant depression with an oral antidepressant
PTSD guideline status	Recommended (WHO 2013; VA/DoD 2023); conditionally recommended (APA 2017)	Not named in WHO, APA, or VA/DoD PTSD guidelines; PTSD use is off-label
Regulatory status	Not a controlled substance	Schedule III controlled substance; Spravato carries a boxed warning and requires monitored administration
Practitioner	Licensed therapist with EMDRIA basic training	Prescriber (MD, DO, NP, or PA); no single national certification for KAP
Can you self-administer it?	Core technique adapts to solo practice	No; requires licensed medical supervision

How do the sessions feel different?

EMDR keeps you present and narrating. Bilateral stimulation runs in short sets, pausing every 20 to 30 seconds so the clinician can ask what surfaced, while you stay oriented to the room and in control of the pace.

Ketamine sessions go the opposite direction. Once the dose takes hold, many people aren’t verbal or fully oriented to their surroundings at all. A clinician or trained sitter monitors vitals and safety rather than actively guiding you through memory work in real time; any “processing” tends to happen afterward, in integration conversations once the drug has worn off.

Some people find that dissociative distance easier to tolerate than staying present with a memory; others find the loss of control harder to sit with than EMDR’s more collaborative pace.

What does the research actually show?

The two approaches aren’t even approved for the same thing, which matters more than most comparisons of this kind admit.

EMDR’s evidence centers on PTSD, and carries real guideline weight there: the World Health Organization’s 2013 guideline and the 2023 VA/DoD clinical practice guideline both recommend it, while the APA’s 2017 guideline recommends it conditionally. See Does EMDR Work? What the Evidence Actually Says for a deeper look, or EMDR and PTSD: What the Research Actually Shows if PTSD specifically is what brought you here.

Ketamine’s only FDA approval sits in a different condition entirely: treatment-resistant depression, not PTSD. That approval rests on trials showing esketamine plus an oral antidepressant outperformed a placebo plus antidepressant on depression scores, which is why the FDA requires it be paired with an antidepressant rather than used alone.

For PTSD specifically, the evidence is real but much thinner. A 2014 randomized controlled trial published in JAMA Psychiatry, led by Feder and colleagues, gave adults with chronic PTSD a single infusion of either ketamine or an active placebo (midazolam). The ketamine group showed significantly greater improvement in PTSD symptom severity, a genuinely encouraging result. But the benefit from that single dose faded within days to weeks, which is exactly why repeated-dose protocols and KAP’s multi-session model exist: one infusion’s effect on trauma symptoms doesn’t hold on its own.

None of that has yet earned ketamine a place in the PTSD guidelines that recommend EMDR. It isn’t named in the WHO, APA, or VA/DoD guidelines cited above. That’s not proof it doesn’t help; it means the larger, replicated trials a guideline recommendation requires haven’t caught up to the early, promising signal yet.

Is ketamine-assisted therapy safe?

Ketamine is a Schedule III controlled substance under the DEA, with real potential for misuse, which is one reason it’s handled so differently from a psychotherapy like EMDR.

Spravato’s FDA approval came with a boxed warning covering sedation, dissociation, and abuse potential, plus a requirement to monitor for worsening depression or suicidal thoughts after each dose. That’s why it can only be administered in a certified healthcare setting, with monitoring for at least two hours afterward, and why patients can’t drive themselves home the same day. Off-label ketamine and KAP sessions carry similar risks: temporary spikes in blood pressure and heart rate, and a dissociative state that makes self-monitoring unreliable, which is exactly why medical supervision isn’t optional here.

If you’re ever in crisis, EmEase’s crisis resources page is here, and in the US you can also call or text 988 anytime.

Which one fits you?

EMDR may fit better if:

• You’re dealing with a specific memory or set of memories, especially trauma-related, and want an approach with strong guideline support.
• You’d rather stay verbal and in control of the pace throughout treatment.
• You want a provider who is, by definition, already a licensed mental health professional.

Ketamine-assisted therapy may fit better if:

• You’ve tried standard antidepressants or trauma therapies without enough relief and are working with a psychiatrist on treatment-resistant depression specifically.
• You’re comfortable with a monitored medical setting and the dissociative experience that comes with it.
• You’re prepared to vet a provider’s training carefully, since the field doesn’t have one unified credential the way EMDR does.

If a more familiar medication route, rather than a dissociative drug, is what you’re actually weighing against EMDR, see EMDR vs SSRIs or EMDR vs Antidepressants.

Worth saying plainly: both are treatments for significant, often stubborn conditions, not everyday stress. That decision belongs with a psychiatrist or therapist who knows your full history, not a comparison article.

Can you practice either one on your own?

Here the two approaches diverge completely.

Ketamine-assisted therapy has no self-guided version. It’s a controlled substance that requires a prescription; using it outside licensed medical supervision is unsafe, since blood pressure changes and dissociation both need a trained person watching, not a phone timer. There’s no lower-stakes version you can try alone, the way EMDR’s core technique allows.

EMDR is different, but only for a much smaller job than either treatment above is meant for. Its core ingredient, bilateral stimulation, can be practiced solo for everyday stress, a tense day or a spike of worry, never as a stand-in for treating diagnosed PTSD or treatment-resistant depression. If you want to try it, read all three steps below before starting.

1. Stabilize first. Spend a minute somewhere calm before working with anything. Picture a real or imagined calm place, or try simple grounding: name what you can see around you, feel your feet on the floor, slow your exhale.

2. Go slow, one moment at a time. Pick a single small, recent stressor, not a diagnosed condition or a heavy trauma memory. Keep the session brief.

3. Know your stop point. If distress climbs above a 7 out of 10 and won’t settle, stop, ground yourself, and consider working with a professional instead of continuing alone. If you’re taking an antidepressant, ketamine, or any other medication as part of a treatment plan, keep following your prescriber’s guidance; never start, stop, or change medication without your prescriber.

With that in place, our beginner’s guide to self-guided bilateral stimulation walks through a full session step by step. Here’s the short version, for one everyday moment:

• Name it and rate it. On a 0–10 scale, how strong is the feeling right now?
• Bring one specific moment to mind, not a whole condition, just this one piece of stress.
• Add bilateral stimulation. Move your eyes slowly left and right for 20–30 seconds, or tap alternating knees or shoulders.
• Pause and notice what shifted, without forcing anything.
• Repeat 3 to 5 short rounds, checking your number again after each one.

EmEase, a self-guided EMDR app, offers this same technique in a guided, paced format if you’d rather not track the timing yourself; you can try it at app.emease.com. It’s a wellness practice inspired by EMDR therapy, not a treatment for depression or PTSD, and not a substitute for either approach in this comparison. Is self-guided EMDR safe? covers that line in more detail.

The bottom line

These two aren’t really rivals for the same choice. EMDR is a well-established, guideline-recommended psychotherapy for PTSD, delivered by a licensed therapist, with a core technique that also scales down safely to solo practice for everyday stress. Ketamine-assisted therapy is a monitored psychiatric drug treatment, FDA-approved only for treatment-resistant depression, with real but much earlier-stage evidence for PTSD, and no self-guided version at all.

If you’re dealing with treatment-resistant depression or PTSD that hasn’t responded to standard care, that conversation belongs with a psychiatrist or therapist who can weigh your full history, not with either name alone. For the everyday stress underneath and around that bigger picture, bilateral stimulation, EMDR’s core technique, is the piece worth practicing on your own today.

Frequently asked questions

Is ketamine-assisted therapy FDA-approved for PTSD?

No. The only FDA-approved form, esketamine (Spravato), is approved solely for treatment-resistant depression alongside an oral antidepressant. Ketamine for PTSD remains off-label. A 2014 randomized trial found real short-term benefit, but ketamine isn’t named in the WHO, APA, or VA/DoD PTSD guidelines that all recommend EMDR.

Can you do ketamine therapy on your own?

No. Ketamine is a Schedule III controlled substance and a dissociative drug; using it without licensed medical supervision is unsafe, and without a prescription it’s illegal. EMDR’s core technique, bilateral stimulation, is different: it’s built to translate into solo practice for everyday stress, not a controlled substance at all.

What is ketamine-assisted therapy used for?

Its only FDA-approved psychiatric use is treatment-resistant depression, via the nasal spray esketamine (Spravato), given with an oral antidepressant. Some clinics and KAP providers also offer off-label ketamine, often paired with therapy sessions, for depression, anxiety, or PTSD, but that use isn’t FDA-approved and rests on thinner research.

Is EMDR safer than ketamine-assisted therapy?

They carry different kinds of risk. EMDR is a psychotherapy with no drug involved; its main caution is going too fast into heavy memories alone. Ketamine carries drug-specific risks, including dissociation, blood pressure changes, and misuse potential, which is why it requires monitored medical administration.

How much training does a ketamine-assisted therapy provider need?

Less standardized than EMDR. A prescriber (MD, DO, NP, or PA) administers or prescribes the ketamine, and a separate therapist may lead preparation and integration sessions. There’s no single national certification like EMDRIA’s, so ask any provider directly about their licensing, training, and monitoring protocol.

Can EMDR and ketamine-assisted therapy be combined?

Some clinicians do combine them, using ketamine’s temporary window of reduced defensiveness to support psychotherapy, sometimes including EMDR-style reprocessing. This pairing is still an emerging practice without robust head-to-head research behind it, so treat it as a question for a licensed provider, not a self-directed choice.